EWP
CLBT icon

Elevation Wealth Partners’s Cellebrite CLBT Stock Holding History

Elevation Wealth Partners’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44K Buy
+3,017
New +$39.9K 0.01% 336

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Elevation Wealth Partners's CLBT Position: Q2 2026 in Review

Elevation Wealth Partners opened a new position in Cellebrite (CLBT) in Q2 2026: 3,017 shares worth $44K. The stake represents 0.01% of the portfolio and ranks #336 among its holdings.

201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Elevation Wealth Partners held 3,017 shares of Cellebrite worth $44K as of Q2 2026.
  • Cellebrite was a new Elevation Wealth Partners position in Q2 2026.
  • Cellebrite made up 0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #336 holding.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.